Inside EU Health Inside EU Health: Co-ordinated pricing and reimbursement; Biotech Act SPC; COVID-19 contracts Beneluxa Initiative calls for pricing and reimbursement coordination; EFPIA argues that the Biotech Act 12-month extension to SPC is too narrow ; AG recommends dismissing Commission appeal on COVID-19 contract access
Biotech Act Commission estimates the cost of Biotech Act protections at €210 million per year A Commission Staff Working Document supporting the Biotech Act I presented in December shows that the estimated cost of an extension to supplementary protection certificates could exceed €210 million per year
Biotech Act Europe pushes to regain ground on competitors with new Biotech Act With the publication of the Biotech Act, the EU sets out how it intends to boost the sector’s competitive position in the face of China’s rapid rise
